Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050332 · ClinicalTrials.gov registry record · NA
Can RFID Technology Capture Stair Walking
A NA study, sponsored by University of Georgia.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04050332: Completed NA study, sponsored by University of Georgia.
NCT04050332 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04050332, a NA study, has completed, sponsored by University of Georgia.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
There are two main aims for this study: 1. conduct a proof-of-concept study illustrating how radio-frequency identification technology can be used to document the timestamps and duration of stair walking (ascending and descending stairs), and detect if an individual is stationary in the stairwell. 2. assess the association of a 4-min bout of self-paced stair walking with changes in blood pressure, mood, and perceived exertion.
Primary Outcome
Duration, in seconds, of stair walking as tracked by the RFID equipment
Interventions
- BEHAVIORAL Stair Walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2019-11-14 |
| Phase | NA |
What the finished NCT04050332 record still lists
NCT04050332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Stair Walking is the first listed.
NCT04050332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04050332 about?
NCT04050332 is a clinical study titled "Can RFID Technology Capture Stair Walking". There are two main aims for this study: 1. conduct a proof-of-concept study illustrating how radio-frequency identification technology can be used to document the timestamps and duration of stair walking (ascending and descending stairs), and detect if an individual is stationary in the stairwell. ...
What is the current status of trial NCT04050332?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2019-10-16. Estimated completion is 2019-11-14.
What interventions are being tested in trial NCT04050332?
The interventions under investigation include: Stair Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT04050332?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04050332's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI